Science Applications Financial Statements (SAIC)
|
|
|
|
Report date
|
|
|
26.03.2021 |
28.03.2022 |
03.02.2023 |
03.04.2023 |
20.03.2024 |
|
05.09.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
7 056 |
7 394 |
7 704 |
7 704 |
7 444 |
|
7 139 |
|
Operating Income, bln rub |
|
|
390.0 |
462.0 |
501.0 |
501.0 |
741.0 |
|
343.0 |
|
EBITDA, bln rub |
? |
|
626.0 |
684.0 |
649.0 |
665.0 |
882.0 |
|
294.0 |
|
Net profit, bln rub |
? |
|
209.0 |
277.0 |
300.0 |
300.0 |
477.0 |
|
236.0 |
|
|
OCF, bln rub |
? |
|
755.0 |
518.0 |
532.0 |
532.0 |
396.0 |
|
362.0 |
|
CAPEX, bln rub |
? |
|
46.0 |
36.0 |
25.0 |
25.0 |
27.0 |
|
23.0 |
|
FCF, bln rub |
? |
|
709.0 |
482.0 |
507.0 |
507.0 |
369.0 |
|
339.0 |
|
Dividend payout, bln rub
|
|
|
87.0 |
86.0 |
83.0 |
83.0 |
79.0 |
|
77.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
41.6% |
31.0% |
27.7% |
27.7% |
16.6% |
|
32.6% |
|
|
OPEX, bln rub |
|
|
348.0 |
341.0 |
374.0 |
374.0 |
131.0 |
|
625.0 |
|
Cost of production, bln rub |
|
|
6 264 |
6 535 |
6 816 |
6 816 |
6 572 |
|
6 332 |
|
R&D, bln rub |
|
|
14.0 |
13.0 |
0.000 |
9.00 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
122.0 |
105.0 |
120.0 |
120.0 |
120.0 |
|
120.0 |
|
|
Assets, bln rub |
|
|
5 723 |
5 746 |
5 543 |
5 543 |
5 314 |
|
5 250 |
|
Net Assets, bln rub |
? |
|
1 542 |
1 619 |
1 694 |
1 694 |
1 785 |
|
1 625 |
|
Debt, bln rub |
|
|
2 720 |
2 710 |
2 526 |
2 526 |
2 246 |
|
2 325 |
|
Cash, bln rub |
|
|
171.0 |
106.0 |
109.0 |
109.0 |
94.0 |
|
48.0 |
|
Net debt, bln rub |
|
|
2 549 |
2 604 |
2 417 |
2 417 |
2 152 |
|
2 277 |
|
|
Ordinary share price, rub |
|
|
96.0 |
81.3 |
104.1 |
104.1 |
129.0 |
|
114.0 |
|
Number of ordinary shares, mln |
|
|
58.1 |
57.6 |
55.3 |
55.3 |
53.1 |
|
50.9 |
|
|
Market cap, bln rub |
|
|
5 579 |
4 684 |
5 756 |
5 756 |
6 850 |
|
5 804 |
|
EV, bln rub |
? |
|
8 128 |
7 288 |
8 173 |
8 173 |
9 002 |
|
8 081 |
|
Book value, bln rub |
|
|
-2 383 |
-2 426 |
-2 226 |
-2 226 |
-1 960 |
|
-2 062 |
|
|
EPS, rub |
? |
|
3.60 |
4.81 |
5.42 |
5.42 |
8.98 |
|
4.64 |
|
FCF/share, rub |
|
|
12.2 |
8.37 |
9.17 |
9.17 |
6.95 |
|
6.66 |
|
BV/share, rub |
|
|
-41.0 |
-42.1 |
-40.3 |
-40.3 |
-36.9 |
|
-40.5 |
|
|
EBITDA margin, % |
? |
|
8.87% |
9.25% |
8.42% |
8.63% |
11.8% |
|
4.12% |
|
Net margin, % |
? |
|
2.96% |
3.75% |
3.89% |
3.89% |
6.41% |
|
3.31% |
|
FCF yield, % |
? |
|
12.7% |
10.3% |
8.81% |
8.81% |
5.39% |
|
5.84% |
|
ROE, % |
? |
|
13.6% |
17.1% |
17.7% |
17.7% |
26.7% |
|
14.5% |
|
ROA, % |
? |
|
3.65% |
4.82% |
5.41% |
5.41% |
8.98% |
|
4.50% |
|
|
P/E |
? |
|
26.7 |
16.9 |
19.2 |
19.2 |
14.4 |
|
24.6 |
|
P/FCF |
|
|
7.87 |
9.72 |
11.4 |
11.4 |
18.6 |
|
17.1 |
|
P/S |
? |
|
0.79 |
0.63 |
0.75 |
0.75 |
0.92 |
|
0.81 |
|
P/BV |
? |
|
-2.34 |
-1.93 |
-2.59 |
-2.59 |
-3.50 |
|
-2.81 |
|
EV/EBITDA |
? |
|
13.0 |
10.7 |
12.6 |
12.3 |
10.2 |
|
27.5 |
|
Debt/EBITDA |
|
|
4.07 |
3.81 |
3.72 |
3.63 |
2.44 |
|
7.74 |
|
|
R&D/CAPEX, % |
|
|
30.4% |
36.1% |
0.00% |
36.0% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.65% |
0.49% |
0.32% |
0.32% |
0.36% |
|
0.32% |
|
| Science Applications shareholders |
